Fearless in Pharma: Addressing Unmet Medical Needs Through Bold Innovation

5,789 new oncology products are currently in development, with 3,677 in phases I and II. Science continues to evolve and provide more patients life-changing therapies, but the commercialization model of these new therapies has not changed in decades – until now. Innovation demands disruptive thinking, and our experts agree. EVERSANA’s Ellen Cappellino sat down with … Continue reading Fearless in Pharma: Addressing Unmet Medical Needs Through Bold Innovation